Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels
- PMID: 17996280
- DOI: 10.1016/j.thromres.2007.09.008
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels
Abstract
Background: Impaired endothelial-dependent flow-mediated dilatation (FMD) has been used to demonstrate endothelial dysfunction in a wide variety of cardiovascular disease, but previous studies have excluded patients with atrial fibrillation(AF). We therefore hypothesised that endothelial dysfunction exists in AF and that this could be demonstrated by impaired FMD, and related to plasma indices of endothelial damage/dysfunction [soluble E-selectin (sE-sel), von Willebrand factor (vWf), and soluble thrombomodulin (sTM)], as well as total body nitrate/nitrite product (NOx, a measure of endothelial nitric oxide production).
Methods: We studied 40 patients with chronic permanent AF, who were compared to 26 sinus rhythm controls. Patients with AF were stable on rate-control and antithrombotic medication and were fasted for the study. High-resolution ultrasound was used to measure right brachial artery diameter at rest, during reactive hyperaemia (endothelium-dependent flow-mediated dilatation) and following endothelium-independent, GTN-mediated dilatation.
Results: Baseline brachial artery diameter did not differ significantly between AF and healthy control subjects. FMD was significantly impaired in AF patients in comparison to healthy controls (8.9% in controls vs 0.0% in AF, p<0.0001). There was no significant difference in endothelium-independent (GTN-induced) dilatation between the groups. Only AF and male sex were independent predictors of impaired FMD on stepwise multiple regression analysis(p<0.0001). sE-sel and vWf were higher in AF than controls (p<0.05), and NOx levels did not reach significance (p=0.1416).
Conclusions: Endothelial dysfunction, as demonstrated by impairment of FMD and raised vWF and E-selectin, is present in AF. Such endothelial perturbation may contribute to the increased risk of stroke and thromboembolism in this common arrhythmia.
Similar articles
-
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.Thromb Haemost. 2005 Oct;94(4):702-6. doi: 10.1160/TH05-02-0093. Thromb Haemost. 2005. PMID: 16270620
-
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.Chest. 2007 Oct;132(4):1253-8. doi: 10.1378/chest.07-1185. Epub 2007 Sep 21. Chest. 2007. PMID: 17890461
-
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.Thromb Res. 2005;116(4):321-5. doi: 10.1016/j.thromres.2005.01.005. Epub 2005 Feb 8. Thromb Res. 2005. PMID: 16038717
-
Endothelial dysfunction and pathophysiological correlates in atrial fibrillation.Heart. 2009 Feb;95(2):102-6. doi: 10.1136/hrt.2007.135277. Heart. 2009. PMID: 19109515 Review.
-
Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.J Autoimmun. 2006 Dec;27(4):211-7. doi: 10.1016/j.jaut.2006.09.008. Epub 2006 Nov 7. J Autoimmun. 2006. PMID: 17088047 Review.
Cited by
-
Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study.Aging (Albany NY). 2020 May 3;12(9):8423-8433. doi: 10.18632/aging.103149. Epub 2020 May 3. Aging (Albany NY). 2020. PMID: 32364529 Free PMC article.
-
Atrial fibrillation, hypertension, and the cerebral vasodilatory reserve.Hypertens Res. 2024 Sep;47(9):2586-2588. doi: 10.1038/s41440-024-01758-9. Epub 2024 Jun 19. Hypertens Res. 2024. PMID: 38898245
-
Brachial flow-mediated dilation and incident atrial fibrillation: the multi-ethnic study of atherosclerosis.Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2717-20. doi: 10.1161/ATVBAHA.114.304560. Epub 2014 Oct 23. Arterioscler Thromb Vasc Biol. 2014. PMID: 25341797 Free PMC article. Clinical Trial.
-
Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.Intern Emerg Med. 2012 Jun;7(3):213-8. doi: 10.1007/s11739-011-0637-0. Epub 2011 Jun 11. Intern Emerg Med. 2012. PMID: 21667071 Review.
-
Vascular Endothelial Dysfunction and Immunothrombosis in the Pathogenesis of Atrial Fibrillation.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241296138. doi: 10.1177/10760296241296138. Clin Appl Thromb Hemost. 2024. PMID: 39654486 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous